8 companies · 5 sourced backers · 57 milestones on record
Programmable life uses biological engineering and computational tools to design DNA, proteins, enzymes and cells for useful tasks. Companies are working to make these designs reliable in manufacturing chemicals, materials and ingredients, while also developing gene and cell therapies for clinical use.
Where the 8 companies stand today, from their profiles and 10-year milestones. Tap a phase to see who is there.
- ▸Making engineered cells perform their intended functions reliably
- ▸Turning designed enzymes into dependable manufacturing tools
- ▸Making biological production commercially workable
- ▸Moving experimental therapies into effective clinical use
Publicly listed: 5 companies (owned by public shareholders).
- ›Every sourced story on all frontiers, filterable by company and news type
- ›10-year milestone records for each company: demo vs shipped
- ›Explained: plain-words readiness diagrams for real breakthroughs
- ›Signal Trends of 39 frontiers covering 378 companies over time.
- ›The events calendar: launches, approvals and deadlines ahead
- Amyris
To use engineered organisms and fermentation to manufacture useful chemicals and ingredients.
Some users · publicly listed
- Arzeda
To design proteins and enzymes computationally for useful industrial applications.
Some users · backed by Continental Grain
- Asimov
To make genetic design and cell engineering more predictable using computational tools and AI.
Some users · backed by Andreessen Horowitz, Casdin Capital
- Codexis
To engineer enzymes that make industrial and pharmaceutical production more effective.
Some users · publicly listed
- Genomatica
To manufacture useful chemicals and materials through biological processes.
Everyone · backed by Casdin Capital, Viking Global
- Ginkgo Bioworks
To make engineering organisms a repeatable service for producing useful biological functions and products.
Some users · publicly listed
- Precigen
To turn its gene- and cell-therapy technologies into treatments that benefit patients.
Some users · publicly listed
- Twist Bioscience
To make synthetic DNA available as a dependable manufactured product using silicon-based production.
Some users · publicly listed
Keep following breakthroughs like these. Every Monday, get up to 5 major breakthroughs and launches explained in plain English.
Free. No account needed. One email a week. Unsubscribe anytime.